185 related articles for article (PubMed ID: 26628205)
1. Transmission of an expanding donor-derived del(20q) clone through allogeneic hematopoietic stem cell transplantation without the development of a hematologic neoplasm.
Aikawa V; Porter D; Luskin MR; Bagg A; Morrissette JJ
Cancer Genet; 2015 Dec; 208(12):625-9. PubMed ID: 26628205
[TBL] [Abstract][Full Text] [Related]
2. Clonal dominance of a donor-derived del(20q) clone after allogeneic hematopoietic stem cell transplantation in an acute myeloid leukemia patient with del(20q).
Yoon J; Yun JW; Jung CW; Kim HJ; Kim SH
J Clin Lab Anal; 2019 Sep; 33(7):e22951. PubMed ID: 31187545
[TBL] [Abstract][Full Text] [Related]
3. Leukemia in donor cells after allogeneic hematopoietic stem cell transplant.
Brunstein CG; Hirsch BA; Hammerschmidt D; McGlennen RC; Nguyen PL; Verfaillie CM
Bone Marrow Transplant; 2002 Jun; 29(12):999-1003. PubMed ID: 12098070
[TBL] [Abstract][Full Text] [Related]
4. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation.
Spinelli O; Giussani U; Borleri G; Lazzari M; Michelato A; Dotti G; Barbui T; Rambaldi A
Haematologica; 2000 Nov; 85(11):1153-7. PubMed ID: 11064467
[TBL] [Abstract][Full Text] [Related]
5. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
Huang X; Liu D
Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow aspirates as part of routine donor assessment for allogeneic blood and marrow transplantation can reveal presence of occult hematological malignancies in otherwise asymptomatic individuals.
Kiss TL; Chang H; Daly A; Messner HA; Jamal N; Spaner D; Rubin S; Lipton JH
Bone Marrow Transplant; 2004 Apr; 33(8):855-8. PubMed ID: 14990983
[TBL] [Abstract][Full Text] [Related]
7. Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant.
Blau IW; Basara N; Bischoff M; Günzelmann S; Römer E; Kirsten D; Schmetzer B; Kiehl MG; Fauser AA
Bone Marrow Transplant; 2000 Jan; 25(1):41-5. PubMed ID: 10654013
[TBL] [Abstract][Full Text] [Related]
8. Donor selection for killer immunoglobulin-like receptors B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation.
Zhou H; Bao X; Wu X; Tang X; Wang M; Wu D; He J
Biol Blood Marrow Transplant; 2014 Jan; 20(1):98-105. PubMed ID: 24516895
[TBL] [Abstract][Full Text] [Related]
9. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.
Hsu KC; Gooley T; Malkki M; Pinto-Agnello C; Dupont B; Bignon JD; Bornhäuser M; Christiansen F; Gratwohl A; Morishima Y; Oudshoorn M; Ringden O; van Rood JJ; Petersdorf E;
Biol Blood Marrow Transplant; 2006 Aug; 12(8):828-36. PubMed ID: 16864053
[TBL] [Abstract][Full Text] [Related]
10. Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT).
Hertenstein B; Hambach L; Bacigalupo A; Schmitz N; McCann S; Slavin S; Gratwohl A; Ferrant A; Elmaagacli A; Schwertfeger R; Locasciulli A; Zander A; Bornhäuser M; Niederwieser D; Ruutu T;
Haematologica; 2005 Jul; 90(7):969-75. PubMed ID: 15996934
[TBL] [Abstract][Full Text] [Related]
11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
12. Donor cell leukemia: a review.
Wiseman DH
Biol Blood Marrow Transplant; 2011 Jun; 17(6):771-89. PubMed ID: 20951819
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic stem cell transplantation for acute myeloid leukemia with del(7q) following untreated chronic lymphocytic leukemia.
DeFilipp Z; Huynh DV; Fazal S; Sahovic E
Hematol Oncol Stem Cell Ther; 2012; 5(3):165-8. PubMed ID: 23095794
[TBL] [Abstract][Full Text] [Related]
14. Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning.
Dreger P; Brand R; Hansz J; Milligan D; Corradini P; Finke J; Deliliers GL; Martino R; Russell N; Van Biezen A; Michallet M; Niederwieser D;
Leukemia; 2003 May; 17(5):841-8. PubMed ID: 12750695
[TBL] [Abstract][Full Text] [Related]
15. Genetically identical twin transplantation for chronic lymphocytic leukemia.
Pavletic SZ; Zhou G; Sobocinski K; Marti G; Doney K; DiPersio J; Feremans W; Foroni L; Goodman S; Prentice G; LeMaistre C; Bandini G; Ferrant A; Jacobsen N; Khouri I; Gale RP; Wiestner A; Giralt S; Montserrat E; Chan WC; Bredeson C;
Leukemia; 2007 Dec; 21(12):2452-5. PubMed ID: 17728782
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia.
Doney KC; Chauncey T; Appelbaum FR;
Bone Marrow Transplant; 2002 May; 29(10):817-23. PubMed ID: 12058231
[TBL] [Abstract][Full Text] [Related]
17. Indications and donor source of hematopoietic stem cell transplants in Europe 1993: report from the European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Hermans J
Clin Transplant; 1995 Oct; 9(5):355-63. PubMed ID: 8541627
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cell transplantation for chronic lymphocytic leukemia.
Gladstone DE; Fuchs E
Curr Opin Oncol; 2012 Mar; 24(2):176-81. PubMed ID: 22234253
[TBL] [Abstract][Full Text] [Related]
19. Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Passweg J; Baldomero H; Hermans J
Bone Marrow Transplant; 1999 Aug; 24(3):231-45. PubMed ID: 10456992
[TBL] [Abstract][Full Text] [Related]
20. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.
Bacigalupo A; Sormani MP; Lamparelli T; Gualandi F; Occhini D; Bregante S; Raiola AM; di Grazia C; Dominietto A; Tedone E; Piaggio G; Podesta M; Bruno B; Oneto R; Lombardi A; Frassoni F; Rolla D; Rollandi G; Viscoli C; Ferro C; Garbarino L; Van Lint MT
Haematologica; 2004 Oct; 89(10):1238-47. PubMed ID: 15477210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
